全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

In Vitro Screening of the Antibacterial Activity of Bidens pilosa Flower Extract against Methicillin-Resistant Staphylococcus aureus Isolated from Wounds of Patients at National Polytechnic University Institute Laboratory

DOI: 10.4236/oalib.1115745, PP. 1-10

Subject Areas: Clinical Medicine, Nursing, Rehabilitation Medicine, Diagnostics

Keywords: Bidens pilosa, Methicillin-Resistant Staphylococcus aureus (MRSA), Wound Infections, Antibacterial Activity

Full-Text   Cite this paper   Add to My Lib

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of wound infections worldwide, associated with delayed healing, prolonged hospital stays, and increased treatment costs. The growing resistance of MRSA to conventional antibiotics highlights the urgent need for alternative therapies. This study evaluated the in vitro antibacterial activity of Bidens pilosa flower extracts against MRSA isolates from wound infections. A laboratory-based experimental design was employed at the National Polytechnic University Institute Laboratory. The fresh plant was collected, washed and dried away from sunlight. It was then crushed and blended to powder form and extraction was done. Extracts were prepared using aqueous, 50% ethanol, and 80% ethanol solvents, and their antibacterial activity was assessed through agar well diffusion and disk diffusion methods, inhibition zone measurements, and minimum inhibitory concentration (MIC) determination. Data was analyzed using SPSS version 23 and presented in tables and figures. Inferential statistics was computed using the t-test and the ANOVA test to assess for differences in mean values. Statistical significance was considered when p value was less than or equal to 0.05. Results showed that the 80% ethanol extract exhibited the strongest antimicrobial activity, producing a mean inhibition zone of 9.8 ± 1.7 mm, significantly higher than the 50% ethanol extract (6.8 ± 1.2 mm) and the aqueous extract (3.7 ± 0.5 mm) (F = 18.5, p = 0.003). Antibacterial activity decreased progressively with dilution, confirming a dose-dependent relationship. At ½ dilution, only the 80% ethanol extract retained activity (3.6 ± 0.6 mm), while aqueous and 50% ethanol extracts lost activity completely (0.0 ± 0.0 mm) (F = 54.3, p < 0.001). At ¼ dilution, the 80% ethanol extract still showed inhibition (2.1 ± 0.3 mm), and at ⅛ dilution, activity persisted (1.1 ± 0.1 mm) (F = 121.6, p < 0.001). MIC testing confirmed that the 80% ethanol extract had a measurable MIC of 12.5 mg/mL, while aqueous and 50% ethanol extracts showed no detectable MIC. Ethanol extracts of Bidens pilosa, particularly at 80% concentration, demonstrate significant antibacterial activity against MRSA, validating its traditional use in wound care. These findings provide preliminary scientific evidence supporting the potential of Bidens pilosa as a locally available, affordable alternative for managing resistant wound infections in resource-limited settings.

Cite this paper

Shalanyuy, L. H. , Samsembom, S. T. , Chongsi, W. E. , Toboh, R. T. and Emlah, N. V. (2026). In Vitro Screening of the Antibacterial Activity of Bidens pilosa Flower Extract against Methicillin-Resistant Staphylococcus aureus Isolated from Wounds of Patients at National Polytechnic University Institute Laboratory. Open Access Library Journal, 13, e15745. doi: http://dx.doi.org/10.4236/oalib.1115745.

References

[1]  World Health Organization (2023) Antimicrobial Resistance: Global Report on Surveillance. WHO.
[2]  Chambers, H.F. and DeLeo, F.R. (2009) Waves of Resistance: <i>Staphylococcus aureus</i> in the Antibiotic Era. <i>Nature</i> <i>Reviews</i> <i>Microbiology</i>, 7, 629-641. <br>https://doi.org/10.1038/nrmicro2200
[3]  Lowy, F.D. (1998) <i>Staphylococcus aureus</i> Infections. <i>New</i> <i>England</i> <i>Journal</i> <i>of</i> <i>Medicine</i>, 339, 520-532. <br>https://doi.org/10.1056/nejm199808203390806
[4]  David, M.Z. and Daum, R.S. (2010) Community-Associated Methicillin-Resistant <i>Staphylococcus aureus</i>: Epidemiology and Clinical Consequences of an Emerging Epidemic. <i>Clinical</i> <i>Microbiology</i> <i>Reviews</i>, 23, 616-687. <br>https://doi.org/10.1128/cmr.00081-09
[5]  Okeke, I.N., Laxminarayan, R., Bhutta, Z.A., Duse, A.G., Jenkins, P., O&#8217;Brien, T.F., <i>et al</i>. (2005) Antimicrobial Resistance in Developing Countries. Part I: Recent Trends and Current Status. <i>The</i> <i>Lancet</i> <i>Infectious</i> <i>Diseases</i>, 5, 481-493. <br>https://doi.org/10.1016/s1473-3099(05)70189-4
[6]  Tong, S.Y.C., Davis, J.S., Eichenberger, E., Holland, T.L. and Fowler, V.G. (2015) <i>Staphylococcus aureus</i> Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. <i>Clinical</i> <i>Microbiology</i> <i>Reviews</i>, 28, 603-661. <br>https://doi.org/10.1128/cmr.00134-14
[7]  Bjarnsholt, T. (2013) The Role of Bacterial Biofilms in Chronic Infections. <i>APMIS</i>, 121, 1-58. <br>https://doi.org/10.1111/apm.12099
[8]  Klein, E., Smith, D.L. and Laxminarayan, R. (2007) Hospitalizations and Deaths Caused by Methicillin-Resistant <i>Staphylococcus aureus</i>, United States, 1999-2005. <i>Emerging</i> <i>Infectious</i> <i>Diseases</i>, 13, 1840-1846. <br>https://doi.org/10.3201/eid1312.070629
[9]  Liu, C., Bayer, A., Cosgrove, S.E., Daum, R.S., Fridkin, S.K., Gorwitz, R.J., <i>et al</i>. (2011) Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Infections in Adults and Children. <i>Clinical</i> <i>Infectious</i> <i>Diseases</i>, 52, e18-e55. <br>https://doi.org/10.1093/cid/ciq146
[10]  Tadesse, B.T., Ashley, E.A., Ongarello, S., Havumaki, J., Wijegoonewardena, M., Gonz&#225;lez, I.J., <i>et al</i>. (2017) Antimicrobial Resistance in Africa: A Systematic Review. <i>BMC Infectious Diseases</i>, 17, Article No. 616. <br>https://doi.org/10.1186/s12879-017-2713-1
[11]  Ventola, C.L. (2015) The Antibiotic Resistance Crisis: Part 1: Causes and Threats. <i>P&T</i>, 40, 277-283.
[12]  World Health Organization (2019) WHO Global Report on Traditional and Complementary Medicine 2019. WHO.
[13]  Cowan, M.M. (1999) Plant Products as Antimicrobial Agents. <i>Clinical Microbiology Reviews</i>, 12, 564-582. <br>https://doi.org/10.1128/cmr.12.4.564
[14]  Bartolome, A.P., Villase&#241;or, I.M. and Yang, W. (2013) <i>Bidens </i><i>pilosa</i> L. (Asteraceae): Botanical Properties, Traditional Uses, Phytochemistry, and Pharmacology. <i>Evidence</i>-<i>Based</i> <i>Complementary</i> <i>and</i> <i>Alternative</i> <i>Medicine</i>, 2013, Article ID: 340215. <br>https://doi.org/10.1155/2013/340215
[15]  Deba, F., Xuan, T.D., Yasuda, M. and Tawata, S. (2008) Chemical Composition and Antioxidant, Antibacterial and Antifungal Activities of the Essential Oils from <i>Bidens </i><i>pilosa</i> Linn. var. Radiata. <i>Food</i> <i>Control</i>, 19, 346-352. <br>https://doi.org/10.1016/j.foodcont.2007.04.011
[16]  Ashafa, A.O.T. and Afolayan, A.J. (2009) Screening the Root Extracts from <i>Bidens </i><i>pilosa</i> L. var. <i>radiata</i> (Asteraceae) for Antimicrobial Potentials. <i>Journal of Medicinal Plants Research</i>, 3, 568-572.
[17]  Cushnie, T.P.T. and Lamb, A.J. (2011) Recent Advances in Understanding the Antibacterial Properties of Flavonoids. <i>International Journal of Antimicrobial Agents</i>, 38, 99-107. <br>https://doi.org/10.1016/j.ijantimicag.2011.02.014
[18]  Clinical and Laboratory Standards Institute (2022) Performance Standards for Antimicrobial Susceptibility Testing. 32nd Edition, CLSI.
[19]  Khan, M.R., Kihara, M. and Omoloso, A.D. (2001) Anti-Microbial Activity of <i>Bidens </i><i>pilosa</i>, <i>Bischofia</i> <i>javanica</i>, <i>Elmerillia</i> <i>papuana</i> and <i>Sigesbekia</i> <i>orientalis</i>. <i>Fitoterapia</i>, 72, 662-665. <br>https://doi.org/10.1016/s0367-326x(01)00261-1
[20]  Eloff, J.N. (1998) Which Extractant Should Be Used for the Screening and Isolation of Antimicrobial Components from Plants? <i>Journal</i> <i>of</i> <i>Ethnopharmacology</i>, 60, 1-8. <br>https://doi.org/10.1016/s0378-8741(97)00123-2
[21]  Kuete, V. (2010) Potential of Cameroonian Plants and Derived Products against Microbial Infections: A Review. <i>Planta Medica</i>, 76, 1479-1491. <br>https://doi.org/10.1055/s-0030-1250027
[22]  Nostro, A., Germano, M.P., D&#8217;Angelo, V., Marino, A. and Cannatelli, M.A. (2000) Extraction Methods and Bioautography for Evaluation of Medicinal Plant Antimicrobial Activity. <i>Letters</i> <i>in</i> <i>Applied</i> <i>Microbiology</i>, 30, 379-384. <br>https://doi.org/10.1046/j.1472-765x.2000.00731.x
[23]  R&#237;os, J.L. and Recio, M.C. (2005) Medicinal Plants and Antimicrobial Activity. <i>Journal</i> <i>of</i> <i>Ethnopharmacology</i>, 100, 80-84. <br>https://doi.org/10.1016/j.jep.2005.04.025
[24]  Hammer, K.A., Carson, C.F. and Riley, T.V. (1999) Antimicrobial Activity of Essential Oils and Other Plant Extracts. <i>Journal</i> <i>of</i> <i>Applied</i> <i>Microbiology</i>, 86, 985-990. <br>https://doi.org/10.1046/j.1365-2672.1999.00780.x

Full-Text


Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133